A dramatic reduction in repeat operations in patients surgically treated for chronic subdural hematoma was achieved when the artery supplying the brain covering was blocked, according to results published in the New England Journal of Medicine.
UB neuroscientists have identified the binding site of low-dose ketamine, providing critical insight into how the medication alleviates symptoms of major depression in as little as a few hours.
Several Jacobs School of Medicine and Biomedical Sciences faculty members received seed funding to support early-stage research projects spanning a variety of age-related conditions and topics.
Jacobs School of Medicine and Biomedical Sciences researchers are conducting a clinical trial to assess the effectiveness of structured financial incentives in lowering cardiovascular disease (CVD) risk among African Americans facing food insecurity.
A paper published today explains why there needs to be a shift in cannabis policies to a public health approach as opposed to the prevailing, more punitive approach that pushes abstinence instead of public education.
A University at Buffalo research program that is investigating what causes some people with multiple sclerosis to experience severe and aggressive disease is beginning to shed light on how their disease differs from those with mild to moderate MS.
